<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A6AC24C-1A8A-4182-A443-95F24864DB56"><gtr:id>8A6AC24C-1A8A-4182-A443-95F24864DB56</gtr:id><gtr:name>Pfizer Global R and D</gtr:name><gtr:address><gtr:line1>Pfizer Global R and D</gtr:line1><gtr:line2>IPC475</gtr:line2><gtr:line3>Ramsgate Road</gtr:line3><gtr:line4>Sandwich</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT13 9NJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90586AE8-B1B4-4D85-B7CC-B9130F248E5C"><gtr:id>90586AE8-B1B4-4D85-B7CC-B9130F248E5C</gtr:id><gtr:name>University of Nebraska-Lincoln</gtr:name><gtr:address><gtr:line1>University of Nebraska-Lincoln</gtr:line1><gtr:line4>Lincoln</gtr:line4><gtr:line5>Nebraska</gtr:line5><gtr:postCode>68588-0340</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/167EE7D9-EC38-4602-862F-F07F7F8B7426"><gtr:id>167EE7D9-EC38-4602-862F-F07F7F8B7426</gtr:id><gtr:name>Da Vinci Communications</gtr:name><gtr:address><gtr:line1>2nd Floor, The Mews</gtr:line1><gtr:line2>Charlton Place</gtr:line2><gtr:line3>Ardwick</gtr:line3><gtr:postCode>M12 6HS</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/84EC36D9-AAC8-496A-B69B-F9DE2213B154"><gtr:id>84EC36D9-AAC8-496A-B69B-F9DE2213B154</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/82CB5BD9-215B-45DE-9EB0-07E1554FB31F"><gtr:id>82CB5BD9-215B-45DE-9EB0-07E1554FB31F</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Owen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DD82B8F7-2993-462C-B5B3-2A50A0CCA662"><gtr:id>DD82B8F7-2993-462C-B5B3-2A50A0CCA662</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:surname>Rannard</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FI038721%2F1"><gtr:id>7B73AD3E-B38F-402D-8FDA-EDB0E49C2D03</gtr:id><gtr:title>New Nanoscale Drug Delivery Systems and their Application to HIV/AIDS treatment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/I038721/1</gtr:grantReference><gtr:abstractText>HIV/AIDS is described by the World Health Organisation as a global pandemic. Estimates show that over 25 million people have died since 1981 and over 33 million people including adults and children are currently living with the disease. In 2005, AIDS claimed an estimated 3.3 million lives globally, including more than 570,000 children. The prevalence of HIV/AIDS continues to increase and it is expected that over 90 million will ultimately be infected in Africa alone. The UK had the highest growth in HIV/AIDS infection in western Europe in the period between 2001 - 2007 with a 64% increase. 

HIV treatment suffers from many issues including the need for patient compliance with a very strict regime of medication. HIV mutation leads to resistance to existing therapies but the ability of therapies to target HIV in the body is critical to the success of medication. HIV resides in various sites throughout the body but there are both cellular and tissue sites which are particularly difficult for drugs to reach. These so called 'sanctuary sites' have the potential to be targeted by particles of drug, rather than dissolved drug molecules. 

Cancer research has shown the benefits of particulate nanomedicine drug delivery approaches. The use of nanoscale polymer carriers which act as vehicles to transport and deliver poorly soluble drugs to the desired site of action, has been beneficial for tumour targeting as the particle nature of the nanomedicine drives the accumulation in tumour tissues. Cellular and tissue sanctuary sites in HIV infection have been widely speculated to also be ideal candidates for particle-based approaches but there has been limited work in this area.

Branched polymers may operate as particle-like drug delivery vehicles and many have been shown to have therapeutic advantages. The best materials are however very expensive to synthesise and would not be viable for treatments in populations such as the sub-Saharan regions (over 20 milllion HIV infections) where cost is a critical component of treatment choice. The University of Liverpool has developed a new class of materials, Polydendrons, that offer many of the benefits of the most sophisticated branched polymers, but can be produced relatively cheaply. In early work, prototype materials have been produced with particle sizes of &amp;gt;40nm and encapsulation capabilities. These materials are unique and still at a very early stage of development. 

This proposal will simultaneously explore the synthesis of Polydendrons and their ability to intervene in HIV treatments. They will be studied as drug carriers of specific size, shape and surface functionality and their ability to target HIV in sanctuary sites will be established. A collaboration between the departments of Chemistry and Molecular and Clinical Pharmacology over 4.5 years is proposed with input from global pharmaceutical companies and HIV clinicians. This approach of material synthesis with integrated pharmacology will considerably accelerate the development of potential new therapies leading to a leading position for the UK that will be applicable to other health issues such as cancer, tuberculosis and hepatitis C.</gtr:abstractText><gtr:potentialImpactText>The key focus of the proposal is the introduction of a new material class and the demonstration of its utility in nanomedicine approaches - initially in improving HIV therapies. Additionally the programme will establish the British Society for Nanomedicine at a highly timely stage in the global investigation of nanotechnology in future therapy development.

The beneficiaries of the research therefore fall into a number of groups including scientists, clinicians, general public, patients and industry. 

The introduction of a new class of materials has been shown many times to ignite new research concepts in fields that often span disciplines that are far removed from the original published concepts. The materials within this proposal are derived from branched polymers and this particular class of materials has shown many times that breakthroughs and new ideas may lead to new companies, commercial impact in existing industries (medicine/engineering/ nanotechnology/data storage/coatings to name a few) and enhance ongoing research programmes. 

Within the field of nanomaterials and nanomedicine, a series of ongoing societal and governmental debates are discussing the safety and application of nanoscale technologies. Uniquely, this programme aims to introduce new nanomaterials, simultaneously evaluate the pharmacology and toxicology of the materials and establish the British Society for Nanomedicine to facilitate contact between researchers, academics/industry and regulators and engagement with the public. Collectively, this will have impact across pharmacology research, drug delivery, polymer materials and nanomaterials researchers. Importantly this proposal seeks to engage with regulatory authorities and generate real data that may impact future policy. We also aim to interact internationally to coordinate nanomedicine activities focussed on drug delivery.

The programme aims to generate therapy options that will be commercially protected and attractive for industrial exploitation. With the correct conversion of therapy options into medicines, the potential impact will spread to clinicians and HIV patients (in the first instance) to improve the care and outcomes within a disease that currently has killed over 25 million people and has 33 million living with HIV. The scale of the potential high impact on HIV patients arises from the need for high levels of patient compliance with therapies that require multiple pills to be taken several times each day over a lifetime. A positive impact on either the required dose of existing drugs, the number of tablets or the number of different drugs used would improve the quality of life for a large number of patients.

The materials proposed are covered by a patent filing that is owned by the University of Liverpool. It is expected that many more patents will flow that potentially will generate a significant commercial opportunity for the UK, initially through a spin-out company and later through production of medicine for international health benefits.

The project seeks to generate convincing chemical and pharmacological data over a 4.5 year period to allow commercial uptake towards the end of the programme. It is important to note that NO NEW DRUGS are being developed and therefore the new delivery vehicles may be seen as excipients for future drugs in mutliple disease areas. It is hoped that within 10 years of the start date, and supported by the critical early data and follow on research, Polydendrons may see themselves in early clinical trials.

Overall, the research proposed has the potential for multiple areas of impact. The researchers employed for the project will be highly trained during the research through exposure to multiple disciplines and therefore be extremely employable on conclusion of this initial research.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2011-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>878568</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>English Language</gtr:department><gtr:description>EU Nanocharacterisation Laboratory</gtr:description><gtr:id>2D03AA4C-9FBF-43FC-80EF-C971104EB9B6</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56b3749247f1c3.81387973-1</gtr:outcomeId><gtr:partnerContribution>Additional input from multiple EU partners to characterise candidate nanomedicines</gtr:partnerContribution><gtr:piContribution>The University of Liverpool team provide critical expertise developed through EPSRC grant funded activity, to the Horizon 2020 funded European Nanocharcterisation Laboratory</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Princes Teaching Institute CPD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B28406AF-33FB-4D18-BE6C-D972502332D5</gtr:id><gtr:impact>CPD for teachers. Presentation designed to update teachers with up to date information to allow teaching knowledge in Nanomedicine</gtr:impact><gtr:outcomeId>56b32187a88655.29854156</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Outreach activity</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C1583CDF-EF3B-4E41-93B9-2D8B08F5D89F</gtr:id><gtr:impact>Vardean College/RSC Sixth former science meeting. Engagement with 6th formers to explain current progress in Nanomedicine</gtr:impact><gtr:outcomeId>56b322c70d1e84.76443301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with industry (Revolymer)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>43F632D5-D4D8-4EE3-BBDA-D84A42916794</gtr:id><gtr:impact>Engagement with research activities and future licence/collaborative research opportunities</gtr:impact><gtr:outcomeId>56b32346216860.26228567</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with Industry (AZ)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FFFDE110-42F8-4ED4-9EA4-9D494993401E</gtr:id><gtr:impact>Significant interest in nanomedicine activities. Event allowed detailed engagement in discussion to evaluate future collaboration activities</gtr:impact><gtr:outcomeId>56b32237492b53.91264229</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website for the British Society for Nanomedicine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9017590F-C7F3-4CAD-A8C7-E7AB55ED41F0</gtr:id><gtr:impact>As part of the creation and launch of the British Society for Nanomedicine as website has been created allowing access to information for children, schools, the public and scientists (academic and industrial)

The Society now has &amp;gt;300 members globally and has held multiple meetings</gtr:impact><gtr:outcomeId>r-143574895.470938562b83d766</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>914582</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Funding for Imaging</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K015931/1</gtr:fundingRef><gtr:id>FED33F19-8E03-40D3-BA1A-FD3DDDA63CC1</gtr:id><gtr:outcomeId>5eded9585eded96c</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovate UK Open Funding Call</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:id>D8F9541A-65C3-4C4F-B1A5-41BAD0A66DBE</gtr:id><gtr:outcomeId>58c9321bca2b12.77611230</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1054422</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Multidisciplinary award</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>21094</gtr:fundingRef><gtr:id>7A7ECC56-AC0C-4EEF-AFEB-8AE79C8D69D8</gtr:id><gtr:outcomeId>56b31cec5f5330.66237219</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The results have generated considerable industrial impact and discussions with several companies across disparate market sectors. Further funding has been received to study the use of the materials in cancer therapies</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>81343240-8614-43FC-B083-30B99E7513AE</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56b37a1e6a4187.76061933</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A method of preparing a non-gelled branched vinyl polymer scaffold carrying dendrons, comprising the living or controlled polymerization of a monofunctional vinyl monomer and a difunctional vinyl monomer, using a dendron initiator and at least one further initiator.</gtr:description><gtr:grantRef>EP/I038721/1</gtr:grantRef><gtr:id>E6154EF1-95AA-4B31-80C7-61B7F2A06BDC</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56b36c053ae1d0.68224736</gtr:outcomeId><gtr:patentId>WO2014199174</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>POLYDENDRONS</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Particles comprising a branched polymer and either a block copolymer or a linear dendritic hybrid represent a category of useful materials. They may be used in for example drug delivery applications. They may be prepared by a method comprising the steps of: dissolving the branched polymer and block copolymer or linear dendritic hybrid, and optionally other component(s),in a solvent to form a solution; adding said solution to a different liquid; and removing said solvent to form a dispersion of co-precipitated particles.</gtr:description><gtr:grantRef>EP/I038721/1</gtr:grantRef><gtr:id>7BC1EF1C-723B-4C78-9BDD-1A07AF9D5AA0</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56b36db6ac1d67.80601757</gtr:outcomeId><gtr:patentId>WO2016009227</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>PARTICLES CONTAINING BRANCHED POLYMERS</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A method of preparing a pH-responsive non-gelled branched vinyl polymer scaffold carrying dendrons, comprismg the living or controlled polymerization of a mono functional vinyl monomer and a difunctional vinyl monomer, using a dendron initiator.</gtr:description><gtr:grantRef>EP/I038721/1</gtr:grantRef><gtr:id>3526904A-2B5B-4DC5-BF15-67BBAB092496</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56b36c810f7757.50002933</gtr:outcomeId><gtr:patentId>WO2014199175</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>POLYDENDRONS</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit- E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).</gtr:description><gtr:grantRef>EP/I038721/1</gtr:grantRef><gtr:id>B16FF707-6F47-4B06-A708-4C21D759A98F</gtr:id><gtr:impact>The patent is supporting a human clinical trial and has initiated interest from global charities and the NIH (US)</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>m-9728776486.337908766747c0</gtr:outcomeId><gtr:patentId>WO2013034925</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>COMPOSITIONS OF EFAVIRENZ</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>A new material platform has been developed that has the potential as a new nanomedicine carrier of drugs</gtr:description><gtr:exploitationPathways>The materials has been licenced to a third party company non-exclusively and also form part of the portfolio for a UoL spinout company</gtr:exploitationPathways><gtr:id>4E5EA494-9E04-4808-BF06-542C99913996</gtr:id><gtr:outcomeId>56b379a71725e7.60051799</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of Innovate UK Emerging Technologies and Industries Steering Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD8203CA-C2F2-434F-BC7B-0991100722F6</gtr:id><gtr:outcomeId>56b3266716d3c3.16330175</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>92FC3E6C-1452-4E8C-8FDE-8245145AFC7D</gtr:id><gtr:title>Architecture-driven aqueous stability of hydrophobic, branched polymer nanoparticles prepared by rapid nanoprecipitation</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06f070e78daf86013b210d1077fe1327"><gtr:id>06f070e78daf86013b210d1077fe1327</gtr:id><gtr:otherNames>Slater Rebecca</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33aa4523994.12352471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12FD728B-133C-4D23-8791-C89556CF1CA4</gtr:id><gtr:title>Controlled synthesis of radiolabelled amine methacrylate water-soluble polymers with end-groups of varying hydrophobicity and studies of adsorption behaviour</gtr:title><gtr:parentPublicationTitle>Polym. Chem.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52fed39faee1afc57f10c96cdaf5ef11"><gtr:id>52fed39faee1afc57f10c96cdaf5ef11</gtr:id><gtr:otherNames>Long M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56b31ae51569f9.95599596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7344D89C-0CBA-4D27-A79A-FF8D256DE538</gtr:id><gtr:title>The application of nanotechnology in medicine: treatment and diagnostics.</gtr:title><gtr:parentPublicationTitle>Nanomedicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf1d6d619c42388d8cdb238501bb7319"><gtr:id>cf1d6d619c42388d8cdb238501bb7319</gtr:id><gtr:otherNames>Owen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1743-5889</gtr:issn><gtr:outcomeId>545e308ee01a58.66656332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FD61E3E-6670-41A0-9C60-928EFC459455</gtr:id><gtr:title>Modulated release from implantable ocular silicone oil tamponade drug reservoirs</gtr:title><gtr:parentPublicationTitle>Journal of Polymer Science Part A: Polymer Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e9b28e9377627241dd3b5246f1ac519"><gtr:id>0e9b28e9377627241dd3b5246f1ac519</gtr:id><gtr:otherNames>Cauldbeck H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a8c1b6f76b762.39797019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA9D3401-EC20-465D-9CC9-DD384C4B674A</gtr:id><gtr:title>Hyperbranched Polydendrons: New branched dendritic-linear hybrid materials for nanomedicine development</gtr:title><gtr:parentPublicationTitle>Converging technology for nanobio-applications of the E-MRS 2014 Spring Meeting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9a218872932a4524de9fd3083c441f4"><gtr:id>b9a218872932a4524de9fd3083c441f4</gtr:id><gtr:otherNames>Hatton F</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e64bf9b4ef5.49614298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0AE23C4-B0D7-4BD9-9C7B-9EADE3F9E9BE</gtr:id><gtr:title>Synthesis of branched polymers by direct one-pot ambient-temperature &amp;quot;living&amp;quot; anionic polymerisation</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5066a419a1074045a3ab7bbf7e4b33"><gtr:id>5b5066a419a1074045a3ab7bbf7e4b33</gtr:id><gtr:otherNames>Alhilfi Tamara</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33aa124c632.84961307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E566D9D1-C074-417F-8E0D-9ED9A26DCE0F</gtr:id><gtr:title>Hyperbranched polydendrons: a new controlled macromolecular architecture with self-assembly in water and organic solvents</gtr:title><gtr:parentPublicationTitle>Chem. Sci.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9a218872932a4524de9fd3083c441f4"><gtr:id>b9a218872932a4524de9fd3083c441f4</gtr:id><gtr:otherNames>Hatton F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545e43a64da5d1.52826712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>379975DE-3E46-4727-9C11-A39CE37C69F8</gtr:id><gtr:title>Stable, polymer-directed and SPION-nucleated magnetic amphiphilic block copolymer nanoprecipitates with readily reversible assembly in magnetic fields.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236f8fefb1de42b371cef64a9fd83257"><gtr:id>236f8fefb1de42b371cef64a9fd83257</gtr:id><gtr:otherNames>Giardiello M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>585d803328fb12.32856789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22A239BE-EA96-42FD-8AEE-A3AA6E50A0D2</gtr:id><gtr:title>Synthesis of branched polymers by direct one-pot ambient-temperature &amp;quot;living&amp;quot; anionic polymerisation</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5066a419a1074045a3ab7bbf7e4b33"><gtr:id>5b5066a419a1074045a3ab7bbf7e4b33</gtr:id><gtr:otherNames>Alhilfi Tamara</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33a9d915680.97005899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E817C0FD-26DF-47DE-9E97-A7F1073A9BDC</gtr:id><gtr:title>Novel surface modification of thiol terminated dendrons with polyethylene glycol using Michael addition thiol-ene click chemistry</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6275448d8f6f075c88ad3446bfee744c"><gtr:id>6275448d8f6f075c88ad3446bfee744c</gtr:id><gtr:otherNames>Auty Sam E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33a9c4355a9.96979736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>803FADF9-7680-4BFF-9F29-9601A83AFEAE</gtr:id><gtr:title>Xanthate Mediated Sequential Thiol-Acrylate Michael Addition</gtr:title><gtr:parentPublicationTitle>8th ECNP International Conference on Nanostructured Polymers and Nanocomposites</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30ed1416f97f8c710859b60364bb63a5"><gtr:id>30ed1416f97f8c710859b60364bb63a5</gtr:id><gtr:otherNames>Hern, F</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e609c5ed628.58310040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7409AD7D-0B13-4F47-8786-DF767D77F516</gtr:id><gtr:title>Emerging nanomedicine applications and manufacturing: progress and challenges.</gtr:title><gtr:parentPublicationTitle>Nanomedicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30e7e2fee983614ddb80b7213d567913"><gtr:id>30e7e2fee983614ddb80b7213d567913</gtr:id><gtr:otherNames>Sartain F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-5889</gtr:issn><gtr:outcomeId>5a8c1cbccc0a05.89802566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D7DD58F-9FFC-4065-9C2E-3987BC595A51</gtr:id><gtr:title>Novel surface modification of thiol terminated dendrons with polyethylene glycol using Michael addition thiol-ene click chemistry</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6275448d8f6f075c88ad3446bfee744c"><gtr:id>6275448d8f6f075c88ad3446bfee744c</gtr:id><gtr:otherNames>Auty Sam E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33a9fb83ca3.12935145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11FCD5EF-871B-40E4-88DE-F07FC6202B3A</gtr:id><gtr:title>Model studies of the sequential and simultaneous statistical modification of dendritic functional groups and their implications within complex polymer architecture synthesis</gtr:title><gtr:parentPublicationTitle>Polymer Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5592752fc559b85fa6027ad25fe6e772"><gtr:id>5592752fc559b85fa6027ad25fe6e772</gtr:id><gtr:otherNames>Hern F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c90f69e04a83.05978488</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFDAA3AF-29FA-4F53-92A1-6644E115D85E</gtr:id><gtr:title>INVITED: Future direction and opportunities of nanomedicine and nanodrug delivery systems'</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48459838935911b680e4543a7fab9f6d"><gtr:id>48459838935911b680e4543a7fab9f6d</gtr:id><gtr:otherNames>Rannard S P</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e77dce20713.11572302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB803FAD-5AC8-4C29-AE1E-CC6E2CB458E1</gtr:id><gtr:title>KEYNOTE: Hyperbranched Polydendrons: New branched dendritic-linear hybrid materials with potential tuneable biological applications</gtr:title><gtr:parentPublicationTitle>8th ECNP International Conference on Nanostructured Polymers and Nanocomposites</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48459838935911b680e4543a7fab9f6d"><gtr:id>48459838935911b680e4543a7fab9f6d</gtr:id><gtr:otherNames>Rannard S P</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e5fa9e1bdc5.18283374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE8112B7-23A8-433F-BDC6-D8214507A7CB</gtr:id><gtr:title>Novel branched dendritic polymers by ATRP: Solvent driven self-assembly</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/987dc3bc1ca57957565bc1a50ad7cd23"><gtr:id>987dc3bc1ca57957565bc1a50ad7cd23</gtr:id><gtr:otherNames>Hatton Fiona L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33bbeee2683.82216003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0180F26-976F-43FE-996B-66C99C73DEC5</gtr:id><gtr:title>Synthesis, nanoprecipitation and pH sensitivity of amphiphilic linear-dendritic hybrid polymers and hyperbranched-polydendrons containing tertiary amine functional dendrons.</gtr:title><gtr:parentPublicationTitle>Soft matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da41dd096107cf69341fe1fc68839d6c"><gtr:id>da41dd096107cf69341fe1fc68839d6c</gtr:id><gtr:otherNames>Rogers HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1744-683X</gtr:issn><gtr:outcomeId>5675e9cbf37a1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FEA6AA1-3B18-4104-B03C-9FEEFE38EC83</gtr:id><gtr:title>Controlling drug release from non-aqueous environments: Moderating delivery from ocular silicone oil drug reservoirs to combat proliferative vitreoretinopathy.</gtr:title><gtr:parentPublicationTitle>Journal of controlled release : official journal of the Controlled Release Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e9b28e9377627241dd3b5246f1ac519"><gtr:id>0e9b28e9377627241dd3b5246f1ac519</gtr:id><gtr:otherNames>Cauldbeck H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-3659</gtr:issn><gtr:outcomeId>58c90f6a3d9e28.08978931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1314BEE1-92D1-4B41-BA1D-6EAC1C9594DB</gtr:id><gtr:title>INVITED: Polydendrons: A New Nanoparticle Platform with Nanomedicine Opportunities</gtr:title><gtr:parentPublicationTitle>Nanomedicine 2014</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48459838935911b680e4543a7fab9f6d"><gtr:id>48459838935911b680e4543a7fab9f6d</gtr:id><gtr:otherNames>Rannard S P</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e638a40d1f3.66362115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A54AF02-4C4D-4A96-99F1-5A2DA8A2DDA8</gtr:id><gtr:title>4th Annual Georgia Nanotechnology and Infectious Disease Symposium</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f1d0b33a9155ad878eeb3bfd94192bb"><gtr:id>5f1d0b33a9155ad878eeb3bfd94192bb</gtr:id><gtr:otherNames>Steve  Rannard (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_1226631533140763a4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6110312E-6968-4974-AD45-115F2E28E01D</gtr:id><gtr:title>Hyperbranched polydendrons: a new nanomaterials platform with tuneable permeation through model gut epithelium.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abef285ce4934bcd5c2290018958e8ec"><gtr:id>abef285ce4934bcd5c2290018958e8ec</gtr:id><gtr:otherNames>Hatton FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>56b31ae37e16a6.96543970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B2A94B6-A653-4319-96B5-1150CB53E464</gtr:id><gtr:title>xanthate deprotection to generate thiol chain transfer agents for conventional free radical linear and branched vinyl polymerization</gtr:title><gtr:parentPublicationTitle>Journal of Polymer Science Part A: Polymer Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0d8e51cc0b319eb307818e9791576cb"><gtr:id>e0d8e51cc0b319eb307818e9791576cb</gtr:id><gtr:otherNames>Flynn S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fecc4344357.83555312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2257B6E4-6601-4503-81EF-F3C47B24A577</gtr:id><gtr:title>Architecture-driven aqueous stability of hydrophobic, branched polymer nanoparticles prepared by rapid nanoprecipitation</gtr:title><gtr:parentPublicationTitle>ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06f070e78daf86013b210d1077fe1327"><gtr:id>06f070e78daf86013b210d1077fe1327</gtr:id><gtr:otherNames>Slater Rebecca</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0065-7727</gtr:issn><gtr:outcomeId>56b33aa16e0b91.58168980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0E39EE1-B18C-4519-8F84-C8F9CB10F915</gtr:id><gtr:title>Exploring the homogeneous controlled radical polymerisation of hydrophobic monomers in anti-solvents for their polymers: RAFT and ATRP of various alkyl methacrylates in anhydrous methanol to high conversion and low dispersity</gtr:title><gtr:parentPublicationTitle>Polymer Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10d7eaffc5e77010f8d32d89f4c29a8"><gtr:id>c10d7eaffc5e77010f8d32d89f4c29a8</gtr:id><gtr:otherNames>Dwyer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56b31ae3c7b115.39350938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7843CCEF-A288-4917-83E4-B133CB60315E</gtr:id><gtr:title>Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf1d6d619c42388d8cdb238501bb7319"><gtr:id>cf1d6d619c42388d8cdb238501bb7319</gtr:id><gtr:otherNames>Owen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>585d60d20c4ff8.37674763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>931A0B88-FEE5-4234-92FE-99986B4F00F8</gtr:id><gtr:title>Architecture-driven aqueous stability of hydrophobic, branched polymer nanoparticles prepared by rapid nanoprecipitation</gtr:title><gtr:parentPublicationTitle>Soft Matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e07ea8974f06f6a3e30c99265196a0"><gtr:id>34e07ea8974f06f6a3e30c99265196a0</gtr:id><gtr:otherNames>Slater R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56b31ae542aac0.82268461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19B93391-7049-4EFB-9786-A5FBAB986878</gtr:id><gtr:title>'One-pot' sequential deprotection/functionalisation of linear-dendritic hybrid polymers using a xanthate mediated thiol/Michael addition</gtr:title><gtr:parentPublicationTitle>Polymer Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eb0dca1b59ac58a5ac249e539493310"><gtr:id>9eb0dca1b59ac58a5ac249e539493310</gtr:id><gtr:otherNames>Auty S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56b31ae42f2ae2.82498706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>090D07C3-0029-4F98-9867-1576B50FDB0B</gtr:id><gtr:title>pH-responsive hyperbranched-Polydendrons for drug delivery applications</gtr:title><gtr:parentPublicationTitle>8th ECNP International Conference on Nanostructured Polymers and Nanocomposites</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5049c05c240fa49248e64adc4289820c"><gtr:id>5049c05c240fa49248e64adc4289820c</gtr:id><gtr:otherNames>Rogers H</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e610e98fee5.52623614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D727098-DDA1-4ACC-BA8E-8747A82D264B</gtr:id><gtr:title>The first peripherally masked thiol dendrimers: a facile and highly efficient functionalization strategy of polyester dendrimers via one-pot xanthate deprotection/thiol-acrylate Michael addition reactions.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8dd93c9a702ea0e515a46b1cd0dc2af5"><gtr:id>8dd93c9a702ea0e515a46b1cd0dc2af5</gtr:id><gtr:otherNames>Auty SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>545e308e6b9671.13073160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>761E50BC-95F8-4E3F-968E-E7A2B76FDB04</gtr:id><gtr:title>Is methanol really a bad solvent for poly(n-butyl methacrylate)? Low dispersity and high molecular weight polymers of n-butyl methacrylate synthesised via ATRP in anhydrous methanol</gtr:title><gtr:parentPublicationTitle>Polym. Chem.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10d7eaffc5e77010f8d32d89f4c29a8"><gtr:id>c10d7eaffc5e77010f8d32d89f4c29a8</gtr:id><gtr:otherNames>Dwyer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56b31ae452ce89.85052786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD84E72A-DCAF-46C3-90F2-F47D81B1EC11</gtr:id><gtr:title>Multiple and Co-Nanoprecipitation Studies of Branched Hydrophobic Copolymers and A-B Amphiphilic Block Copolymers, Allowing Rapid Formation of Sterically Stabilized Nanoparticles in Aqueous Media</gtr:title><gtr:parentPublicationTitle>Macromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75ead6a36ef5b2f4f39fc1e5178cfe3"><gtr:id>a75ead6a36ef5b2f4f39fc1e5178cfe3</gtr:id><gtr:otherNames>Ford J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5675efccba3ec</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>748E78DF-D7FF-4176-87F6-18A3E77E9F24</gtr:id><gtr:title>Inaugural Meeting of the British Society for Nanomedicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91e7fdbac79e2e16955c5bf004c271a8"><gtr:id>91e7fdbac79e2e16955c5bf004c271a8</gtr:id><gtr:otherNames>Andrew  Owen (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_366070296513d7cc34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7532481D-3F6A-4595-9458-145E15FA2425</gtr:id><gtr:title>Considerations for clinically-relevant nanomedicine therapies for chronic diseases.</gtr:title><gtr:parentPublicationTitle>Nanomedicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf1d6d619c42388d8cdb238501bb7319"><gtr:id>cf1d6d619c42388d8cdb238501bb7319</gtr:id><gtr:otherNames>Owen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1743-5889</gtr:issn><gtr:outcomeId>56b31ae3f20457.21548573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81A79849-7C97-4F27-A248-A668C2BA7BF0</gtr:id><gtr:title>Role of highly branched, high molecular weight polymer structures in directing uniform polymer particle formation during nanoprecipitation.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abef285ce4934bcd5c2290018958e8ec"><gtr:id>abef285ce4934bcd5c2290018958e8ec</gtr:id><gtr:otherNames>Hatton FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>585d7d090f9cf0.26187848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>800BA275-B362-42AB-B7F5-DF48D6CFA7E1</gtr:id><gtr:title>Synthesis and thermal studies of aliphatic polyurethane dendrimers: a geometric approach to the Flory-Fox equation for dendrimer glass transition temperature</gtr:title><gtr:parentPublicationTitle>Soft Matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e001608f61b34f2514c1e65966480dc"><gtr:id>0e001608f61b34f2514c1e65966480dc</gtr:id><gtr:otherNames>Stoddart A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56b31ae4a194c1.61293516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61CE4F48-7CC1-46ED-999C-270CDA6AF72F</gtr:id><gtr:title>A Novel Approach to Sterically Stabilised Loaded Nanoparticles from a Hydrophobic Branched Polymer and an Amphiphilic Block Copolymer</gtr:title><gtr:parentPublicationTitle>8th ECNP International Conference on Nanostructured Polymers and Nanocomposites</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a75ead6a36ef5b2f4f39fc1e5178cfe3"><gtr:id>a75ead6a36ef5b2f4f39fc1e5178cfe3</gtr:id><gtr:otherNames>Ford J</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e61c0a51210.95708403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEC3735F-26D3-4FA2-903C-6C664A0C52F3</gtr:id><gtr:title>Monitoring Atom Transfer Radical Polymerisation using
 
 C-radiolabelled initiators</gtr:title><gtr:parentPublicationTitle>Polym. Chem.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52fed39faee1afc57f10c96cdaf5ef11"><gtr:id>52fed39faee1afc57f10c96cdaf5ef11</gtr:id><gtr:otherNames>Long M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>56b31ae56b08d9.79768895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EC7D90E-C8E7-48B2-B3F1-F8C21F70183C</gtr:id><gtr:title>pH-responsive hyperbranched-Polydendrons for drug delivery applications</gtr:title><gtr:parentPublicationTitle>8th ECNP International Conference on Nanostructured Polymers and Nanocomposites</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5049c05c240fa49248e64adc4289820c"><gtr:id>5049c05c240fa49248e64adc4289820c</gtr:id><gtr:otherNames>Rogers H</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>545e6117d02821.83963861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68BFEE40-788C-4BF2-AB52-6172DF73BCDD</gtr:id><gtr:title>Synthesis and in vivo magnetic resonance imaging evaluation of biocompatible branched copolymer nanocontrast agents.</gtr:title><gtr:parentPublicationTitle>International journal of nanomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cae4f235033252a0af5255c27a27b06f"><gtr:id>cae4f235033252a0af5255c27a27b06f</gtr:id><gtr:otherNames>Jackson AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1176-9114</gtr:issn><gtr:outcomeId>56b31ae309e8b3.28212098</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/I038721/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>E847DD9B-2053-4BC7-97A9-4213B185C968</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Materials sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>B30DC286-3309-48E2-A15D-BDF547057A33</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Drug Formulation &amp; Delivery</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>561091A1-9FC9-4508-B1B2-2F3623E1FC9D</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Materials Characterisation</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>063026C5-CD0B-48AB-82F3-6359499A95D4</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Materials Synthesis &amp; Growth</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>